Drug Shortage Report for IMITREX

Last updated on 2020-10-08 History
Report ID 125057
Drug Identification Number 02212188
Brand name IMITREX
Common or Proper name Sumatriptan succinate injection
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) SUMATRIPTAN
Strength(s) 6MG
Dosage form(s) LIQUID
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 2x0.5mL
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-09-24
Estimated end date 2020-10-14
Actual end date 2020-10-05
Shortage status Resolved
Updated date 2020-10-08
Company comments
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-10-08 French Compare
v3 2020-10-08 English Compare
v2 2020-09-25 French Compare
v1 2020-09-25 English Compare